WASHINGTON - Australian and Canadian researchers have developed a new therapy that specifically targets cancer stem cells in acute myeloid leukaemia.
The rules, the agency said, lay out which research is eligible for federal funding and help “ensure that NIH-funded research in this area is ethically responsible, scientifically worthy and conducted in accordance with applicable law.”
WASHINGTON - A piece of research has shown that it is possible to eliminate stem cells related to human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer, using a new targeted therapy.
STANFORD University, in California, USA, has been the pioneer for many researches in stem cell therapeutics. It is moving very fast, and aiming to make stem cell therapy available to the patients’ bed in almost every other case. Be it cancer or Parkinson’s, stem cell research and Stanford University is becoming synonyms for cure.
ICT-121 is an immunotherapy that targets cancer stem cells
ImmunoCellular Therapeutics, Ltd. announced on June 18th 2009, about the filing of the U.S. patient application relating to its novel vaccine technology ICT-121 targeting cancer stem cells.
Researchers at the National Cancer Institute, a part of the National Institutes of Health find out a new approach to generate a power packed anti-tumor response in mice, by stimulating immune cells anti cancer activity.
Caught in the web of dilemmas? Just read through ten best success stories compiled just for you. We are sure you will take up the challenge and let you or your loved ones find a respite from the grueling pains.
A team of haematologists lead by Dr, Ashis Mukhopadhyay at Netaji Subhash Chandra Bose Cancer Institute, Kolkata, performed a successful autologus stem cell transplant to an eight year old girl who was suffering from neuroblastoma, a kind of cancer.
Stem cells of an unknown long distant donor saved the life of Bob Winkelmann, a 67 years old retired businessman suffering from acute myeloid leukemia for years.
Much hue and cry took place when in 2001 George W. Bush put a ban in embryonic stem cell (ES) research. Scientists from different communities talked against it, while the people defending their ethical reasons supported it.